Product Code: GVR-4-68040-307-3
Brain Imaging Devices Market Growth & Trends:
The global brain imaging devices market size is estimated to reach USD 9.03 billion by 2030, registering to grow at a CAGR of 8.2% from 2025 to 2030 according to a new report by Grand View Research, Inc. Key drivers propelling market growth include technological advancements, increasing R&D activities, and the growing prevalence of brain or neurological disorders. For instance, the International Agency for Research on Cancer reported approximately 321,731 cases of brain and central nervous system cancer worldwide in 2022. This type of cancer was noted to rank 19th among all other types of cancer.
Technological advancements are expected to be one of the primary factors contributing to market growth. These advancements encompass a spectrum of innovations, including enhanced imaging resolution, improved data processing capabilities, and the development of novel imaging modalities. Such progress not only enhances the accuracy and efficiency of brain imaging but also expands its applications across various fields such as neuroscience, neurology, psychiatry, and neurosurgery. For instance, in February 2024, Philips partnered with Synthetic MR, a company specializing in magnetic resonance imaging (MRI) software solutions, to introduce Smart Quant Neuro 3D, marking a notable advancement in providing objective decision support for the diagnosis and assessment of therapy effectiveness in brain disorders like multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. The Smart Quant Neuro 3D technology provides automated measurements of various brain tissues, aids in decision-making for brain diseases, monitors disease progression, and assesses therapy results.
Additionally, the rising prevalence of neurological disorders and an aging population contribute to the increasing demand for advanced brain imaging technologies. With continuous research and development efforts driving innovation and the expansion of the market. Furthermore, various initiatives undertaken by market players are further expected to contribute to market growth. For instance, in November 2022, Neurosteer secured FDA approval for its single-channel electroencephalogram (EEG) brain monitoring platform. The company innovatively improved the conventional EEG system by incorporating an adhesive-backed electrode strip, seamlessly linking to a compact sensor, thus offering a more simplified and user-friendly solution.
Brain Imaging Devices Report Highlights:
- The devices segment dominated the market with the largest revenue share of 81.5% in 2024.
- The brain tumor segment held the largest revenue share in 2024, attributed to the increasing prevalence of the condition.
- The fixed segment dominated the brain imaging devices industry with the largest revenue share in 2024.
- The hospital segment held the largest revenue share in 2024.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. Modality
- 1.2.4. End Use
- 1.2.5. Regional Scope
- 1.2.6. Estimates and Forecasts Timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.4.5. Details of Primary Research
- 1.5. Information or Data Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. Application Outlook
- 2.2.3. Modality Outlook
- 2.2.4. End Use Outlook
- 2.2.5. Regional Outlook
- 2.3. Competitive Scenario
Chapter 3. Brain Imaging Devices Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Brain Imaging Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrant
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political Landscape
- 3.3.2.2. Technological Landscape
- 3.3.2.3. Economic Landscape
Chapter 4. Brain Imaging Devices Market: Product Estimates & Trend Analysis
- 4.1. Product Segment Dashboard
- 4.2. Brain Imaging Devices Market: Product Movement Analysis
- 4.3. Global Brain Imaging Devices Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
- 4.4. Devices
- 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.2. EEG
- 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.3. MEG
- 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.4. MRI
- 4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.5. CT
- 4.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.6. PET
- 4.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.7. Other Devices
- 4.4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5. Accessories
- 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5.2. Electrodes
- 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5.3. Sensors
- 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5.4. Other Accessories
- 4.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Brain Imaging Devices Market: Application Estimates & Trend Analysis
- 5.1. Application Segment Dashboard
- 5.2. Brain Imaging Devices Market: Application Movement Analysis
- 5.3. Global Brain Imaging Devices Market Size & Trend Analysis, By Application, 2018 to 2030 (USD Million)
- 5.4. Stroke
- 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.5. Brain Tumor
- 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.6. Traumatic Brain Injury (TBI)
- 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.7. Epilepsy
- 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.8. Sleep Apnea
- 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.9. Headache
- 5.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.10. Structural Anomalies
- 5.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.11. Other Applications
- 5.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Brain Imaging Devices Market: Modality Estimates & Trend Analysis
- 6.1. Modality Segment Dashboard
- 6.2. Brain Imaging Devices Market: Modality Movement Analysis
- 6.3. Global Brain Imaging Devices Market Size & Trend Analysis, By Modality, 2018 to 2030 (USD Million)
- 6.4. Fixed
- 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5. Portable
- 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.6. Wearable
- 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Brain Imaging Devices Market: End Use Estimates & Trend Analysis
- 7.1. End Use Segment Dashboard
- 7.2. Brain Imaging Devices Market: End Use Movement Analysis
- 7.3. Global Brain Imaging Devices Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
- 7.4. Hospital
- 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5. Diagnostic Imaging Centers
- 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6. Ambulatory Surgery Centers
- 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7. Other End Users
- 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. Brain Imaging Devices Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Dashboard
- 8.2. Regional Market Share Analysis, 2024 & 2030
- 8.3. Brain Imaging Devices Market by Region: Key Takeaways
- 8.4. North America
- 8.4.1. U.S.
- 8.4.1.1. Key Country Dynamics
- 8.4.1.2. Regulatory Framework/ Reimbursement Structure
- 8.4.1.3. Competitive Scenario
- 8.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.4.2. Canada
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Regulatory Framework/ Reimbursement Structure
- 8.4.2.3. Competitive Scenario
- 8.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.4.3. Mexico
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Regulatory Framework/ Reimbursement Structure
- 8.4.3.3. Competitive Scenario
- 8.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5. Europe
- 8.5.1. U.K.
- 8.5.1.1. Key Country Dynamics
- 8.5.1.2. Regulatory Framework/ Reimbursement Structure
- 8.5.1.3. Competitive Scenario
- 8.5.1.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.2. Germany
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Regulatory Framework/ Reimbursement Structure
- 8.5.2.3. Competitive Scenario
- 8.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.3. France
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Regulatory Framework/ Reimbursement Structure
- 8.5.3.3. Competitive Scenario
- 8.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.4. Italy
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Regulatory Framework/ Reimbursement Structure
- 8.5.4.3. Competitive Scenario
- 8.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.5. Spain
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Regulatory Framework/ Reimbursement Structure
- 8.5.5.3. Competitive Scenario
- 8.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.6. Denmark
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Regulatory Framework/ Reimbursement Structure
- 8.5.6.3. Competitive Scenario
- 8.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.7. Sweden
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Regulatory Framework/ Reimbursement Structure
- 8.5.7.3. Competitive Scenario
- 8.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.8. Norway
- 8.5.8.1. Key Country Dynamics
- 8.5.8.2. Regulatory Framework/ Reimbursement Structure
- 8.5.8.3. Competitive Scenario
- 8.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.1.1. Key Country Dynamics
- 8.6.1.2. Regulatory Framework/ Reimbursement Structure
- 8.6.1.3. Competitive Scenario
- 8.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.2. China
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Regulatory Framework/ Reimbursement Structure
- 8.6.2.3. Competitive Scenario
- 8.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.3. India
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Regulatory Framework/ Reimbursement Structure
- 8.6.3.3. Competitive Scenario
- 8.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.4. Australia
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Regulatory Framework/ Reimbursement Structure
- 8.6.4.3. Competitive Scenario
- 8.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.5. South Korea
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Regulatory Framework/ Reimbursement Structure
- 8.6.5.3. Competitive Scenario
- 8.6.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.6. Thailand
- 8.6.6.1. Key Country Dynamics
- 8.6.6.2. Regulatory Framework/ Reimbursement Structure
- 8.6.6.3. Competitive Scenario
- 8.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.7. Latin America
- 8.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.7.2. Brazil
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Regulatory Framework/ Reimbursement Structure
- 8.7.2.3. Competitive Scenario
- 8.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.7.3. Argentina
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Regulatory Framework/ Reimbursement Structure
- 8.7.3.3. Competitive Scenario
- 8.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8. Middle East and Africa
- 8.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8.2. South Africa
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Regulatory Framework/ Reimbursement Structure
- 8.8.2.3. Competitive Scenario
- 8.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8.3. Saudi Arabia
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Regulatory Framework/ Reimbursement Structure
- 8.8.3.3. Competitive Scenario
- 8.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8.4. UAE
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. Regulatory Framework/ Reimbursement Structure
- 8.8.4.3. Competitive Scenario
- 8.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8.5. Kuwait
- 8.8.5.1. Key Country Dynamics
- 8.8.5.2. Regulatory Framework/ Reimbursement Structure
- 8.8.5.3. Competitive Scenario
- 8.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/ Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. Key Company Heat Map Analysis, 2024
- 9.4. Company Profiles
- 9.4.1. GE HealthCare
- 9.4.1.1. Company Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Koninklijke Philips N.V.
- 9.4.2.1. Company Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. Siemens Healthineers AG
- 9.4.3.1. Company Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Medtronic
- 9.4.4.1. Company Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Compumedics Limited
- 9.4.5.1. Company Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. MEGIN
- 9.4.6.1. Company Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. CTF MEG NEURO INNOVATIONS, INC.
- 9.4.7.1. Company Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. FieldLine Inc.
- 9.4.8.1. Company Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Cerca Magnetics Limited
- 9.4.9.1. Company Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. Advanced Brain Monitoring, Inc.
- 9.4.10.1. Company Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Strategic Initiatives
- 9.4.11. Canon Medical Systems Corporation
- 9.4.11.1. Company Overview
- 9.4.11.2. Financial Performance
- 9.4.11.3. Product Benchmarking
- 9.4.11.4. Strategic Initiatives
- 9.4.12. Natus
- 9.4.12.1. Company Overview
- 9.4.12.2. Financial Performance
- 9.4.12.3. Product Benchmarking
- 9.4.12.4. Strategic Initiatives
- 9.4.13. Magstim EGI
- 9.4.13.1. Company Overview
- 9.4.13.2. Financial Performance
- 9.4.13.3. Product Benchmarking
- 9.4.13.4. Strategic Initiatives
- 9.4.14. Cadwell Industries Inc.
- 9.4.14.1. Company Overview
- 9.4.14.2. Financial Performance
- 9.4.14.3. Product Benchmarking
- 9.4.14.4. Strategic Initiatives
- 9.4.15. Nihon Kohden Corporation
- 9.4.15.1. Company Overview
- 9.4.15.2. Financial Performance
- 9.4.15.3. Product Benchmarking
- 9.4.15.4. Strategic Initiatives
- 9.4.16. NeuroLogica Corp.
- 9.4.16.1. Company Overview
- 9.4.16.2. Financial Performance
- 9.4.16.3. Product Benchmarking
- 9.4.16.4. Strategic Initiatives